Greenwich LifeSciences, Inc. (GLSI)
NASDAQ·Healthcare·Biotechnology
$23.20
-3.29%
Mkt Cap $335.42M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.30 | -$0.30 | +0.00% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.24 | -$0.30 | -25.00% | — | — |
| Q2 2025 May 20, 2025 | — | — | — | -$0.24 | -$0.25 | -4.17% | — | — |
| Q2 2025 Apr 15, 2025 | — | $3.61K | — | -$0.21 | -$0.61 | -190.48% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.21 | -$0.20 | +4.76% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.20 | -$0.20 | +0.00% | — | — |
| Q2 2024 May 20, 2024 | — | — | — | -$0.20 | -$0.19 | +5.00% | — | — |
| Q2 2024 Apr 15, 2024 | — | $5.42K | — | -$0.20 | -$0.21 | -5.00% | — | — |
| Q4 2023 Oct 19, 2023 | — | — | — | -$0.22 | -$0.19 | +13.64% | — | — |
| Q3 2023 Aug 21, 2023 | — | — | — | -$0.23 | -$0.13 | +43.48% | — | — |
| Q2 2023 May 22, 2023 | — | — | — | -$0.23 | -$0.17 | +26.09% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$0.18 | -$0.22 | -22.22% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.19 | -$0.18 | +5.26% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.19 | -$0.06 | +68.42% | — | — |
| Q2 2022 May 20, 2022 | — | — | — | -$0.19 | -$0.15 | +21.05% | — | — |
| Q1 2022 Mar 21, 2022 | — | — | — | -$0.07 | -$0.18 | -157.14% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.06 | -$0.07 | -16.67% | — | — |
| Q3 2021 Aug 13, 2021 | — | — | — | — | -$0.06 | — | — | — |
| Q2 2021 May 20, 2021 | — | — | — | -$0.26 | -$0.05 | +80.77% | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | -$0.93 | -$0.12 | +87.10% | — | — |